Rocket One Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Rocket One Inc. (RKTO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 6.99 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.94M shares, a 8.85% increase year-over-year.
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.70M shares, a 39.30% decline year-over-year.
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 4.46M shares, a 43.24% increase year-over-year.
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 4.39M shares, a 764.24% increase year-over-year.
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.29M shares, a 43.54% increase from fiscal 2023.
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.38M shares, a 758.25% increase from fiscal 2022.
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 510.88K shares, a 12.09% increase from fiscal 2021.
- Rocket One Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 455.79K shares, a 76.44% decline from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.99M shares 10-Q · filed 2026-08-14 | ||||||||
| 2026-03-31 | 2.94M shares 10-Q · filed 2026-05-15 | ||||||||
| 2025-12-31 | 2.70M shares 10-Q · filed 2026-05-15 | 3.00M shares 10-K · filed 2026-03-27 | |||||||
| 2025-09-30 | 3.00M shares 10-Q · filed 2025-11-12 | ||||||||
| 2025-06-30 | 3.00M shares 10-Q · filed 2026-08-14 | ||||||||
| 2025-03-31 | 2.70M shares 10-Q · filed 2025-05-12 | ||||||||
| 2024-12-31 | 6.29M shares 10-K · filed 2026-03-27 | ||||||||
| 2024-09-30 | 6.30M shares 10-Q · filed 2025-11-12 | ||||||||
| 2024-06-30 | 5.83M shares 10-Q · filed 2025-08-12 | ||||||||
| 2024-03-31 | 4.46M shares 10-Q · filed 2025-05-12 | ||||||||
| 2023-12-31 | 4.38M shares 10-K · filed 2025-03-28 | ||||||||
| 2023-09-30 | 4.39M shares 10-Q · filed 2023-11-13 | 4.39M shares 10-Q · filed 2024-11-12 | |||||||
| 2023-06-30 | 3.11M shares 10-Q · filed 2023-08-11 | 3.11M shares 10-Q · filed 2024-08-09 | |||||||
| 2023-03-31 | 3.11M shares 10-Q · filed 2024-05-14 | ||||||||
| 2022-12-31 | 510.88K shares 10-K · filed 2024-03-28 | ||||||||
| 2022-09-30 | 507.53K shares 10-Q · filed 2023-11-13 | 507.53K shares 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | 507.57K shares 10-Q · filed 2023-08-11 | 507.57K shares 10-Q · filed 2023-08-11 | 12.69M shares 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | 507.57K shares 10-Q · filed 2023-05-15 | 12.69M shares 10-Q · filed 2022-05-12 | |||||||
| 2021-12-31 | 455.79K shares 10-K · filed 2023-03-31 | 11.39M shares 10-K · filed 2022-03-30 | |||||||
| 2021-09-30 | 455.81K shares 10-Q · filed 2022-11-10 | 11.40M shares 10-Q · filed 2021-11-10 | |||||||
| 2021-06-30 | 11.60M shares 10-Q · filed 2022-08-12 | ||||||||
| 2021-03-31 | 12.37M shares 10-Q · filed 2021-05-13 | ||||||||
| 2020-12-31 | 1.93M shares 10-K · filed 2022-03-30 | ||||||||
| 2020-09-30 | 1.99M shares 10-Q · filed 2021-11-10 | ||||||||
| 2020-06-30 | 1.70M shares 10-Q · filed 2021-08-11 | ||||||||
| 2020-03-31 | 1.63M shares 10-Q · filed 2021-05-13 | ||||||||
| 2019-12-31 | 1.57M shares 10-K · filed 2021-03-16 | ||||||||
| 2019-09-30 | 1.05M shares 10-Q · filed 2020-11-10 | ||||||||
| 2019-06-30 | 785.23K shares 10-Q · filed 2020-08-13 | ||||||||
| 2019-03-31 | 1.06M shares 10-Q · filed 2020-05-13 | ||||||||
| 2018-12-31 | 4.12M shares 10-K · filed 2020-03-02 | ||||||||
| 2018-09-30 | 4.09M shares 10-Q · filed 2019-11-12 | ||||||||
| 2018-06-30 | 4.09M shares 10-Q · filed 2019-08-14 | ||||||||
| 2018-03-31 | 4.09M shares 10-Q · filed 2019-05-15 | ||||||||
| 2017-12-31 | 2.37M shares 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |